Table 2.
Prevalence of neurological manifestations in children by the DENV serotypes detected in CSF
| Neurological manifestation (%) | DENV-1 | DENV-2 | DENV-3 | DENV-4 | DENV 1/2/3 | p-value* |
|---|---|---|---|---|---|---|
| Seizures | 31.2 | 41.6 | 27.8 | 33.3 | 42.8 | 0.921 |
| Encephalitis | 31.2 | 26.7 | 27.8 | 33.3 | 28.6 | 0.928 |
| Meningitis | 18.7 | 8.3 | 27.8 | 33.3 | 28.6 | 0.702 |
| Bulging fontanel | 18.7 | 16.7 | 22.2 | 33.3 | 0 | 0.687 |
| Motor symptoms secondary encephalitis, myelitis or ADEM | 6.2 | 26.7 | 11.1 | 0 | 0 | 0.715 |
| PNS involvement | 0 | 0 | 11,1 | 0 | 14.3 | 0.402 |
| Focal signs | 6.2 | 16.7 | 5.6 | 0 | 14.3 | 0.769 |
| Ataxia | 6.2 | 8.3 | 11.1 | 0 | 14.3 | 0.939 |
| Intracranial hypertension | 0 | 0 | 5.5 | 0 | 14.3 | 0.450 |
| SNC image was taken | 25 | 50 | 44.4 | 33.3 | 42.8 | 0.694 |
| SNC image was altered | 25 | 33.3 | 37.5 | 100 | 66.7 | 0.580 |
| EEG was taken | 12.5 | 16.7 | 22.2 | 33.3 | 28.6 | 0.849 |
| EEG was altered | 50 | 0 | 0 | 0 | 50 | 0.369 |
| NEUROLOGICAL COMPLICATIONS AFTER HOSPITAL DISCHARGE (%) | ||||||
| Discharge with some neurological complication | 37.5 | 50 | 27.8 | 66.7 | 28.7 | 0.582 |
| Use of anticonvulsant | 12.5 | 25 | 16.7 | 33.3 | 28.6 | 0.818 |
| Motor complications | 6.2 | 16.7 | 11.1 | 0 | 14.3 | 0.872 |
| Headache | 6.2 | 0 | 11.1 | 0 | 0 | 0.654 |
| Sleep disturbance | 25 | 16.7 | 5.6 | 33.3 | 0 | 0.316 |
*p-value = Z test of proportions